Response to Wagner et al.: phosphodiesterase-2-anti-adrenergic friend or hypertrophic foe in heart disease?
Department of Cardiology, Cardiovascular Division, British Heart Foundation Centre, King's College London, London, UK.
Anna
A
Zoccarato
Translational Medicine and Therapeutics, John Vane Science Centre, Charterhouse Square, Queen Mary University of London, London, UK.
Laura H
LH
Fields
Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, UK. manuela.zaccolo@dpag.ox.ac.uk.
Manuela
M
Zaccolo
D018674:Adrenergic Antagonists; D006331:Heart Diseases; D006801:Humans; D006984:Hypertrophy; D010727:Phosphoric Diester Hydrolases
D018674:Adrenergic Antagonists; D010727:Phosphoric Diester Hydrolases
J Am Coll Cardiol. 2013 Oct 22;62(17):1596-606
23810893
Circ Res. 2011 Apr 15;108(8):929-39
21330599
Cell Signal. 2016 Jul;28(7):725-32
26475678
Circ Res. 2015 Sep 25;117(8):707-19
26243800
Naunyn Schmiedebergs Arch Pharmacol. 2016 Nov;389(11):1139-1141
27553701
Nat Med. 2000 May;6(5):482-3
10802676